Earnings call briefThird-quarter 2026
Abbott Laboratories says it plans to separate its nutrition business
Abbott Laboratories said it expects to complete the separation by the end of next year, subject to required approvals.
GetSignal Abbott Laboratories ABT
Abbott Laboratories said on its third-quarter call that it plans a tax-free distribution of its nutrition business to Abbott shareholders. It said it is planning for the new company to raise debt, with part of the proceeds going to Abbott Laboratories; amounts are to be set later. It also said it expects sales growth to accelerate by 50 to 100 basis points after the separation, excluding nutrition.
Quotes from the call
“The new nutrition company will become a publicly traded company through a planned tax-free distribution to Abbott shareholders.”
Key facts from the call
- Expected separation completion
- End of next year, subject to required approvals
- Expected sales growth change after separation, excluding nutrition
- Increase of 50 to 100 basis points
- Expected gross margin change after separation, excluding nutrition
- Increase of more than 200 basis points
Source: Abbott Laboratories' third-quarter 2026 earnings call, October 21, 2026.
Written by GetSignal with AI from the company's earnings call.
Not investment advice.
More earnings call briefs
- Constellation Energy expects nuclear uprate costs of about $4.3 billion
CEG Constellation Energy Q3 2026 call
- Howard Hughes Holdings says its insurance ambition is a return on equity in excess of 20%
HHH Howard Hughes Holdings Q3 2026 call
- Brookfield Asset Management now sees 2026 earnings modestly below early view
BAM Brookfield Asset Management Q3 2026 call
- Enbridge says it expects 2026 results at the midpoint of its guidance range
ENB Enbridge Q3 2026 call
- TeraWulf sees about half of contracted IT capacity earning revenue by end of Q1
WULF TeraWulf Q3 2026 call
